Advancing the Millennium Development Goals

In 2000 global leaders met and established what have become known as the Millennium Development Goals (MDGs), focused on alleviating the suffering of the world's poorest people. These goals address poverty and hunger, disease, maternal health, child mortality, gender equality, education, environmental sustainability and the need for a partnership to advance global development.

Pfizer strongly supports all eight goals, but we know we can help advance some of these goals more effectively than others. We are working hard to improve access to essential medicines in developing countries and underserved areas, focusing on strengthening the capacity of health partners and systems to support access to care that ranges from disease prevention to early diagnosis and effective treatment.

Pfizer is well suited to help combat readily preventable or treatable diseases that affect the developing world. Through the Advanced Market Commitment initiative, we are supplying Prevenar 13 for pediatric use to the least-developed countries to help combat pneumococcal disease, the leading cause of vaccine-preventable death worldwide among children younger than five. Through our ViiV Healthcare joint venture with GlaxoSmithKline, we are striving to find medicines to help avoid and treat HIV infection, the world's leading cause of death in women during their childbearing years, and to make these medicines more accessible to patients who need them. We have made our proprietary library available to help combat neglected diseases. And we continue to transform our business—and forge purpose-built partnerships with stakeholders and peers—so that we are better able to serve the needs of people everywhere with new, life-enhancing health care solutions.